NCT07316816 Stanford Pediatric Healthy Weight Index
| NCT ID | NCT07316816 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Obesity & Overweight |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-01-05 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2026-01-05 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will develop a simple index to measure how well the body uses insulin and overall heart and metabolic health in children and teens with obesity. The investigators will use data from wearable devices (like fitness trackers) and glucose monitors, along with lab tests, to learn how activity and glucose relate to metabolic problems.
Eligibility Criteria
Inclusion Criteria: * Class 2 and 3 obesity * Patient in the Adolescent Bariatric Program at Stanford Children's that is eligible for either laparoscopic sleeve gastrectomy or GLP1 Receptor Agonist Therapy * Willingness to wear a CGM and physiological monitor for the duration of the study. Exclusion Criteria: * Hypothalamic and syndromic obesity * BMI \> 55 * Plan to undergo bariatric surgical procedure other than sleeve gastrectomy * Prior bariatric surgical procedure * Active GLP treatment (within past 3 months) * Unable to read, understand, or complete the informed consent in English or Spanish
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07316816 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 18 Years, studying Obesity & Overweight. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07316816 currently recruiting?
Yes, NCT07316816 is actively recruiting participants. Contact the research team at karls@stanford.edu for enrollment information.
Where is the NCT07316816 trial being conducted?
This trial is being conducted at Palo Alto, United States.
Who is sponsoring the NCT07316816 clinical trial?
NCT07316816 is sponsored by Stanford University. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.